Table 3.

Chemotherapy and Radiotherapy Adverse Events.

	Melatonin N (%)	Placebo N (%)	P Value
Attributed to Chemotherapy	44 (66.7)	48 (70.6)	0.62
Attributed to Radiation	8 (36.4)	5 (23.8)	0.37

Number of participants who experienced adverse events related to chemotherapy and radiation therapy. Participants were included if they were given adjuvant chemotherapy or radiation and experienced an adverse event. Attribution required the adverse event to be at least possibly related to the chemotherapy or radiation under the discretion of the treating surgeon. Chemotherapy: Melatonin (N = 66); Placebo (N = 68). Radiotherapy: Melatonin (N = 22); Placebo (N = 21).